Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Burrows, G.G.
Right arrow Articles by Vandenbark, A.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burrows, G.G.
Right arrow Articles by Vandenbark, A.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Protein Engineering, Vol. 12, No. 9, 771-778, September 1999
© 1999 Oxford University Press

Design, engineering and production of functional single-chain T cell receptor ligands

G.G. Burrows1,2,3,4,4, J.W. Chang1, H-P. Bächinger2,5, D.N. Bourdette1,6, H. Offner1,4,4 and A.A. Vandenbark1,3,4,4

1 Department of Neurology, 2 Department of Biochemistry and Molecular Biology and 4 Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, 3 Neuroimmunology Research and 6 Neurology Service, Veterans Affairs Medical Center and 5 Shriners Hospital for Children, Portland, Oregon 97201, USA

Major histocompatibility complex (MHC) class II molecules are membrane-anchored heterodimers on the surface of antigen presenting cells (APCs) that bind the T cell receptor, initiating a cascade of interactions that results in antigen-specific activation of clonal populations of T cells. The peptide binding/T cell recognition domains of rat MHC class II (alpha-1 and beta-1 domains) were expressed as a single exon for structural and functional characterization. These recombinant single-chain T cell receptor ligands (termed `ß1{alpha}1' molecules) of approximately 200 amino acid residues were designed using the structural backbone of MHC class II molecules as template, and have been produced in Escherichia coli with and without N-terminal extensions containing antigenic peptides. Structural characterization using circular dichroism predicted that these molecules retained the antiparallel ß-sheet platform and antiparallel {alpha}-helices observed in the native MHC class II heterodimer. The proteins exhibited a cooperative two-state thermal folding–unfolding transition. ß1{alpha}1 molecules with a covalently linked MBP-72–89 peptide showed increased stability to thermal unfolding relative to the empty ß1{alpha}1 molecules. This new class of small soluble polypeptide provides a template for designing and refining human homologues useful in detecting and regulating pathogenic T cells.

Keywords: ß1{alpha}1/drug design/immunotherapy/MHC class II/TCR ligand

4 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 StrokeHome page
S. Subramanian, B. Zhang, Y. Kosaka, G. G. Burrows, M. R. Grafe, A. A. Vandenbark, P. D. Hurn, and H. Offner
Recombinant T Cell Receptor Ligand Treats Experimental Stroke
Stroke, July 1, 2009; 40(7): 2539 - 2545.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Sinha, S. Subramanian, L. Miller, T. M. Proctor, C. Roberts, G. G. Burrows, A. A. Vandenbark, and H. Offner
Cytokine Switch and Bystander Suppression of Autoimmune Responses to Multiple Antigens in Experimental Autoimmune Encephalomyelitis by a Single Recombinant T-Cell Receptor Ligand
J. Neurosci., March 25, 2009; 29(12): 3816 - 3823.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Huan, L. J. Kaler, J. L. Mooney, S. Subramanian, C. Hopke, A. A. Vandenbark, E. F. Rosloniec, G. G. Burrows, and H. Offner
MHC Class II Derived Recombinant T Cell Receptor Ligands Protect DBA/1LacJ Mice from Collagen-Induced Arthritis
J. Immunol., January 15, 2008; 180(2): 1249 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Sinha, S. Subramanian, T. M. Proctor, L. J. Kaler, M. Grafe, R. Dahan, J. Huan, A. A. Vandenbark, G. G. Burrows, and H. Offner
A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS
J. Neurosci., November 14, 2007; 27(46): 12531 - 12539.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. P. Fontenot, T. S. Keizer, M. McCleskey, D. G. Mack, R. Meza-Romero, J. Huan, D. M. Edwards, Y. K. Chou, A. A. Vandenbark, B. Scott, et al.
Recombinant HLA-DP2 Binds Beryllium and Tolerizes Beryllium-Specific Pathogenic CD4+ T Cells
J. Immunol., September 15, 2006; 177(6): 3874 - 3883.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. L. Jones, S. E. Brophy, A. J. Bankovich, L. A. Colf, N. A. Hanick, K. C. Garcia, and D. M. Kranz
Engineering and Characterization of a Stabilized {alpha}1/{alpha}2 Module of the Class I Major Histocompatibility Complex Product Ld
J. Biol. Chem., September 1, 2006; 281(35): 25734 - 25744.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
G. Adamus, G. G. Burrows, A. A. Vandenbark, and H. Offner
Treatment of Autoimmune Anterior Uveitis with Recombinant TCR Ligands.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2555 - 2561.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Offner, S. Subramanian, C. Wang, M. Afentoulis, A. A. Vandenbark, J. Huan, and G. G. Burrows
Treatment of Passive Experimental Autoimmune Encephalomyelitis in SJL Mice with a Recombinant TCR Ligand Induces IL-13 and Prevents Axonal Injury
J. Immunol., September 15, 2005; 175(6): 4103 - 4111.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Huan, S. Subramanian, R. Jones, C. Rich, J. Link, J. Mooney, D. N. Bourdette, A. A. Vandenbark, G. G. Burrows, and H. Offner
Monomeric Recombinant TCR Ligand Reduces Relapse Rate and Severity of Experimental Autoimmune Encephalomyelitis in SJL/J Mice through Cytokine Switch
J. Immunol., April 1, 2004; 172(7): 4556 - 4566.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Wang, J. L. Mooney, R. Meza-Romero, Y. K. Chou, J. Huan, A. A. Vandenbark, H. Offner, and G. G. Burrows
Recombinant TCR Ligand Induces Early TCR Signaling and a Unique Pattern of Downstream Activation
J. Immunol., August 15, 2003; 171(4): 1934 - 1940.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. H. McMahan, L. Watson, R. Meza-Romero, G. G. Burrows, D. N. Bourdette, and A. C. Buenafe
Production, Characterization, and Immunogenicity of a Soluble Rat Single Chain T Cell Receptor Specific for an Encephalitogenic Peptide
J. Biol. Chem., August 15, 2003; 278(33): 30961 - 30970.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. A. Vandenbark, C. Rich, J. Mooney, A. Zamora, C. Wang, J. Huan, L. Fugger, H. Offner, R. Jones, and G. G. Burrows
Recombinant TCR Ligand Induces Tolerance to Myelin Oligodendrocyte Glycoprotein 35-55 Peptide and Reverses Clinical and Histological Signs of Chronic Experimental Autoimmune Encephalomyelitis in HLA-DR2 Transgenic Mice
J. Immunol., July 1, 2003; 171(1): 127 - 133.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. G. Burrows, Y. K. Chou, C. Wang, J. W. Chang, T. P. Finn, N. E. Culbertson, J. Kim, D. N. Bourdette, D. A. Lewinsohn, D. M. Lewinsohn, et al.
Rudimentary TCR Signaling Triggers Default IL-10 Secretion by Human Th1 Cells
J. Immunol., October 15, 2001; 167(8): 4386 - 4395.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. G. Burrows, K. L. Adlard, B. F. Bebo Jr., J. W. Chang, K. Tenditnyy, A. A. Vandenbark, and H. Offner
Regulation of Encephalitogenic T Cells with Recombinant TCR Ligands
J. Immunol., June 15, 2000; 164(12): 6366 - 6371.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. W. Chang, D. E. Mechling, H.-P. Bachinger, and G. G. Burrows
Design, Engineering, and Production of Human Recombinant T Cell Receptor Ligands Derived from Human Leukocyte Antigen DR2
J. Biol. Chem., June 22, 2001; 276(26): 24170 - 24176.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.